Highlights

• Ryman Healthcare gained 1.48% to $1.71 on 4 September 2026

• FY2026 first-half free Cash Flow of NZ$56 million — first positive result in over a decade

• Company listed on the ASX in October 2025 following a refreshed strategy

• Ryman operates 49 retirement villages across New Zealand and Australia

Ryman Healthcare Ltd (ASX:RYM) edged higher by 1.48% to $1.71 on 4 September 2026. The New Zealand retirement village operator has been generating fresh interest from Australian investors since its ASX listing in October 2025, and a landmark first-half result showing positive free cash flow for the first time in over a decade is a key part of that renewed narrative.

About the Company

Ryman Healthcare is one of Australasia's largest and most recognised operators of integrated retirement villages and aged care facilities. Founded in New Zealand in 1984, the company has built a network of 49 villages across New Zealand and Australia. Ryman's villages integrate independent living, serviced apartments and hospital-level aged care, supported by a vertically integrated development and operations model. After several years of financial pressure related to development activity, Ryman has been implementing a strategic reset focused on financial discipline.

Key Developments

Ryman Healthcare's FY2026 first-half results recorded free cash flow of NZ$56 million, marking its first positive free-cash-flow result in more than a decade. The company has also pursued a refreshed strategy following its ASX listing in October 2025. Ryman operates 49 retirement villages across New Zealand and Australia.

Key Catalysts to Watch

• Sustained positive free cash flow in the second half and full year of FY2026

• Progress on the strategic reset including village development pipeline management

• Increased investor interest from the Australian market following the ASX listing

• Retirement sector tailwinds from ageing demographics in NZ and Australia

Risks

• New Zealand property market conditions affecting retirement unit sales and resales

• Ongoing Debt levels from historical development activity

• Execution risk on the strategic reset in a challenging macroeconomic environment

• Currency exposure given NZD-denominated earnings

Conclusion

Ryman Healthcare's first positive free cash flow in more than a decade is a genuinely significant milestone that signals meaningful progress on its financial reset. The 1.48% gain on 4 September reflects growing confidence that the refreshed strategy is gaining traction. With an ageing demographic providing structural tailwinds and the ASX listing opening up a new investor base, Ryman may be an interesting recovery story for patient investors prepared to navigate the NZ property cycle.